USFDA completes inspection at Ajanta Pharma’s Dahej formulation facility

26 Jun 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Ajanta Pharma’s Dahej formulation facility. At the end of inspection, USFDA issued no Form 483 to the said facility. The formulation facility at Dahej was inspected by US FDA from June 19, 2023 to June 23, 2023.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×